These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27390252)

  • 1. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
    Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
    Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
    Dehnes Y; Shalina A; Myrvold L
    Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interference of heparin on IEF-PAGE of erythropoietins.
    Reichel C; Benetka E; Geisendorfer T; Scheiblhofer V; Abzieher F
    Drug Test Anal; 2010; 2(11-12):568-75. PubMed ID: 21204288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection methods significantly increase the detection window for EPO microdoses.
    Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A
    Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
    Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
    Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
    Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
    Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.
    Reichel C; Benetka W; Lorenc B; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y; Hemmersbach P
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of microdoses of rhEPO with the MAIIA test.
    Mørkeberg J; Sharpe K; Karstoft K; Ashenden MJ
    Scand J Med Sci Sports; 2014 Aug; 24(4):634-41. PubMed ID: 23347069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol.
    Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M
    Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.
    Reichel C
    Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination methods for erythropoietin receptor activator in human urine].
    Xing YY; Zhang LS; Xu YX; Wu MT; Wang S
    Yao Xue Xue Bao; 2009 Jul; 44(7):820-3. PubMed ID: 19806926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin.
    Voss S; Lüdke A; Romberg S; Schänzer E; Flenker U; deMarees M; Achtzehn S; Mester J; Schänzer W
    Int J Sports Med; 2010 Jun; 31(6):367-71. PubMed ID: 20419620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric analysis of EPO IEF-PAGE interfering substances in nitrile examination gloves.
    Reichel C
    Drug Test Anal; 2012 Oct; 4(10):761-74. PubMed ID: 23081906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing.
    Reichel C; Thevis M
    Drug Test Anal; 2012 Nov; 4(11):818-29. PubMed ID: 22764129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse.
    Cox HD; Miller GD; Manandhar A; Husk JD; Crouch AK; Eichner D
    Am J Hematol; 2021 Dec; 96(12):1621-1629. PubMed ID: 34626008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
    Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.